#AstraZeneca for the first time admits its Covishield vaccine may lead to rare side effect
![]() 30392 Tuesday, 30 April, 2024, 23:24 AstraZeneca has admitted for the first time in court documents that its Covid-19 vaccine, sold globally under the brand names Covishield and Vaxzevria among others, may lead to a rare side-effect. Covishield can cause, in rare cases, a condition that leads to blood clots and low platelet count, the vaccine-maker has said in court documents. This condition is known as Thrombosis with Thrombocytopenia Syndrome (TTS). Covishield was produced by the Serum Institute of India and widely administered in the country. AstraZeneca is facing a class action lawsuit in the UK over claims that its vaccine caused deaths and severe injuries in several cases. |
Kenya's refugee camps suffer as US slashes aid (video)
224211.08.2025, 23:36US considering China travel warning after nearly 5,000 cases of deadly virus: report
353003.08.2025, 18:12Armenian doctor helps 14-year-old girl give birth during earthquake
313930.07.2025, 16:00Doctors in Kamchatka continued surgery during earthquake (video)
327730.07.2025, 10:44Trump says Coca-Cola agreed to use real cane sugar in US
406617.07.2025, 09:48White House doctor says Trump is 'fully fit' in medical report
977513.04.2025, 23:03Chinese team finds new bat coronavirus that could infect humans
1126021.02.2025, 11:20"Don't lose hope if you struggle with acne," advises Dr. Maria Novosartyan (photo)
589009.01.2025, 22:06